latest news in Life Sciences

Karolinska Development Details SEK 202M Rights Issue and Rebrands as KDventures

Solna, Friday, 9 January 2026.
Rebranding as KDventures, the firm targets SEK 202.6 million in fresh capital. Investors face a 5:2 subscription ratio to fund Nordic life science expansion starting January 13.

Tecan Signals Market Recovery with Return to Sales Growth in Late 2025

Männedorf, Friday, 9 January 2026.
Tecan posted a critical turnaround, with order entry rising 3.8% to CHF 900.9 million, indicating a robust recovery in pharmaceutical capital spending is finally underway.